The ACHILLES project will train a new generation of researchers in experimental haemato-oncology to tackle leukaemia and lymphoma January 29, 2026 The ACHILLES project will train a new generation of researchers in experimental haemato-oncology to tackle leukaemia and lymphoma
Mariona Graupera and Anna Bigas receive two ERC Synergy Grants to foster innovative knowledge on haematological disorders November 05, 2024 Mariona Graupera and Anna Bigas receive two ERC Synergy Grants to foster innovative knowledge on haematological disorders
Intrinsic factors of the CAR-T cells may play a major role on its clinical success October 29, 2024 Intrinsic factors of the CAR-T cells may play a major role on its clinical success
Spanish Cooperative Group of Haematological Cytogenetics: 30 years of advances in the study of cytogenetics October 25, 2024 Spanish Cooperative Group of Haematological Cytogenetics: 30 years of advances in the study of cytogenetics
First patient in the world treated with a new therapeutic strategy to target cancer stem cells October 21, 2024 First patient in the world treated with a new therapeutic strategy to target cancer stem cells
Understanding the maturation of white blood cells to find new therapies against lymphoblastic leukaemia October 18, 2024 Understanding the maturation of white blood cells to find new therapies against lymphoblastic leukaemia
Dr. Mariona Graupera participates in the ADAPTMET project: training the future experts in metastasis research October 17, 2024 Dr. Mariona Graupera participates in the ADAPTMET project: training the future experts in metastasis research
Dr. Marcus Buschbeck's group will seek to identify new drugs to fight acute myeloid leukaemia with the support of la Caixa Foundation October 14, 2024 Dr. Marcus Buschbeck's group will seek to identify new drugs to fight acute myeloid leukaemia with the support of la Caixa Foundation
Cord blood cells can build a better human immune system into mice October 11, 2024 Cord blood cells can build a better human immune system into mice
The impact of TP53 mutations in del5q Myelodysplastic Syndromes unveiled October 09, 2024 The impact of TP53 mutations in del5q Myelodysplastic Syndromes unveiled
An epigenetic characteristic help predict efficacy of immunotherapy in multiple myeloma October 07, 2024 An epigenetic characteristic help predict efficacy of immunotherapy in multiple myeloma
%20i%20Dra.%20Anna%20Bigas%20(dreta),%20investigadores%20de%20l'Institut%20Josep%20Carreras.png.png?locale=en)
.png?locale=en)
